These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36686780)

  • 21. Epigenome-Wide Analysis of Methylation Changes in the Sequence of Gallstone Disease, Dysplasia, and Gallbladder Cancer.
    Brägelmann J; Barahona Ponce C; Marcelain K; Roessler S; Goeppert B; Gallegos I; Colombo A; Sanhueza V; Morales E; Rivera MT; de Toro G; Ortega A; Müller B; Gabler F; Scherer D; Waldenberger M; Reischl E; Boekstegers F; Garate-Calderon V; Umu SU; Rounge TB; Popanda O; Lorenzo Bermejo J
    Hepatology; 2021 Jun; 73(6):2293-2310. PubMed ID: 33020926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased expression of hsa‑miR‑372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1.
    Zhou N; Cheng W; Peng C; Liu Y; Jiang B
    Mol Med Rep; 2017 Nov; 16(5):7848-7854. PubMed ID: 28944858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
    Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y
    J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ERK/MAPK pathway is overexpressed and activated in gallbladder cancer.
    Buchegger K; Silva R; López J; Ili C; Araya JC; Leal P; Brebi P; Riquelme I; Roa JC
    Pathol Res Pract; 2017 May; 213(5):476-482. PubMed ID: 28285962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression profile of cholecystokinin type-A receptor in gallbladder cancer and gallstone disease.
    Rai R; Tewari M; Kumar M; Singh TB; Shukla HS
    Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):408-14. PubMed ID: 21813391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer.
    Zhou Z; Peng Y; Wu X; Meng S; Yu W; Zhao J; Zhang H; Wang J; Li W
    Cell Oncol (Dordr); 2019 Feb; 42(1):81-92. PubMed ID: 30276551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo.
    Qin Y; Zhou Y; Ge A; Chang L; Shi H; Fu Y; Luo Q
    Biomed Pharmacother; 2019 Oct; 118():109266. PubMed ID: 31401397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulated NOX1 expression in gallbladder cancer‑associated fibroblasts predicts a poor prognosis.
    Wang FT; Hassan M; Ansari KH; Xu GL; Li XP; Fan YZ
    Oncol Rep; 2019 Oct; 42(4):1475-1486. PubMed ID: 31364740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression.
    Wang S; Zhang Y; Cai Q; Ma M; Jin LY; Weng M; Zhou D; Tang Z; Wang JD; Quan Z
    Mol Cancer; 2019 Oct; 18(1):145. PubMed ID: 31623628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of adrenergic receptor gene polymorphisms in gallbladder cancer susceptibility in a North Indian population.
    Rai R; Sharma KL; Misra S; Kumar A; Mittal B
    J Cancer Res Clin Oncol; 2014 May; 140(5):725-35. PubMed ID: 24556804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Taurine chloramine selectively regulates neutrophil degranulation through the inhibition of myeloperoxidase and upregulation of lactoferrin.
    Kim DG; Kwon YM; Kang IS; Kim C
    Amino Acids; 2020 Aug; 52(8):1191-1199. PubMed ID: 32865666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic Downregulation of PTEN in Gallbladder Cancer.
    Tekcham DS; Gupta S; Shrivastav BR; Tiwari PK
    J Gastrointest Cancer; 2017 Mar; 48(1):110-116. PubMed ID: 28124240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of cell cycle as the critical pathway modulated by exosome-derived microRNAs in gallbladder carcinoma.
    Su L; Zhang J; Zhang X; Zheng L; Zhu Z
    Med Oncol; 2021 Oct; 38(12):141. PubMed ID: 34655361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysine-specific demethylase 1 promotes tumorigenesis and predicts prognosis in gallbladder cancer.
    Lian SX; Shao YB; Liu HB; He JY; Lu WQ; Zhang Y; Jiang Y; Zhu J
    Oncotarget; 2015 Oct; 6(32):33065-76. PubMed ID: 26460616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p.
    Goeppert B; Truckenmueller F; Ori A; Fritz V; Albrecht T; Fraas A; Scherer D; Silos RG; Sticht C; Gretz N; Mehrabi A; Bewerunge-Hudler M; Pusch S; Bermejo JL; Dietrich P; Schirmacher P; Renner M; Roessler S
    Sci Rep; 2019 Mar; 9(1):4796. PubMed ID: 30886199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular pathogenesis of gallbladder cancer: An update.
    Mishra SK; Kumari N; Krishnani N
    Mutat Res; 2019 Nov; 816-818():111674. PubMed ID: 31330366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA aberrations: An emerging field for gallbladder cancer management.
    Chandra V; Kim JJ; Mittal B; Rai R
    World J Gastroenterol; 2016 Feb; 22(5):1787-99. PubMed ID: 26855538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA expression profiles in gallbladder carcinoma identified using microarray analysis.
    Wang J; Liu H; Shen X; Wang Y; Zhang D; Shen S; Suo T; Pan H; Ming Y; Ding K; Liu H
    Oncol Lett; 2017 May; 13(5):3508-3516. PubMed ID: 28529578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated serum triglyceride levels may be a key independent predicting factor for gallbladder cancer risk in gallbladder stone disease patients: a case-control study.
    Wan Y; Zhang J; Chen M; Ma M; Sheng B
    BMC Endocr Disord; 2022 Nov; 22(1):270. PubMed ID: 36348328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer.
    Wei D; Rui B; Qingquan F; Chen C; Ping HY; Xiaoling S; Hao W; Jun G
    Int J Biol Sci; 2021; 17(2):514-526. PubMed ID: 33613109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.